Navigation Links
Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora
Date:10/23/2008

NERVIANO, Italy, October 23 /PRNewswire/ --

- First Responses in Solid Tumours Reported.

Aurora inhibitors play a key role in cell duplication and are implicated in both the onset and progression of numerous types of tumour. A lecture focusing on Aurora kinase inhibitors will be presented today by Dr. Bernard Laffranchi during the 20th EORTC-NCI-AACR Symposium "Molecular Targets and Cancer Therapeutics" organised from 21st to 24th October 2008 in Geneva. Dr Laffranchi, Director Clinical Research of Nerviano Medical Sciences, the largest R&D cancer drug stand alone company in Europe (http://www.nervianoms.com) has been invited to give a presentation on the state-of-the-art of Aurora kinase inhibitors, providing a comprehensive summary of ongoing clinical studies being performed on this molecular target to which increasing attention is being paid by the experts.

"Nerviano Medical Sciences (NMS) has been chosen by these prestigious scientific societies in view of the fact that the Italian centre has a recognized leadership in research & development of Aurora inhibitors," explains Francesco Colotta, Research & Development Director at NMS. Indeed, compounds capable of inhibiting activity of this kinase family and displaying anti-tumour efficacy in a wide range of solid and blood cancers models were first identified at Nerviano. Moreover, emphasises Dr. Colotta, the Aurora inhibitors discovered at Nerviano were the first to be evaluated in patients and to undergo clinical development.

"This symposium will be organised in a particularly pragmatic fashion and provides a wide-ranging overview of all data collected with regard to future treatment of patients," underlines Dr. Colotta. "Preliminary results of human clinical Phase II trials with Aurora inhibitors carried out by NMS are underway," continues Dr. Colotta. The product at the most advanced stage of development is PHA 739358, a se
'/>"/>

SOURCE Nerviano Medical Sciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
2. TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
3. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
4. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
5. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
6. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
7. International Medical Corps Matched with Top 25 American Express Members Project, Saving the Lives of Malnourished Children
8. Concentric Medical to Sponsor Randomized Trial
9. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
10. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
11. 7 Health Ventures Invests in Tulip Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... N.J. , July 25, 2014  Acsis ... brand protection and serialization solutions, has recently posted ... that addresses current and future needs for ... for the old supply chain model no longer ... in technology, including the growth of mobile technology, ...
(Date:7/25/2014)...  IDEXX Laboratories, Inc. (NASDAQ: IDXX ) ... 2014 increased 11% versus the prior year period to ... second quarter of 2014 versus the prior year period ... inventory 2 . Earnings per diluted share ("EPS") for ... the prior year period to $1.10."In the second quarter, ...
(Date:7/25/2014)... 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... and report second quarter 2014 financial results before the ... 2014. That same day, Arena will host a conference ... a.m. Pacific Time). The conference call ... and 914.495.8552 for international callers. Please specify to the ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2
(Date:7/28/2014)... Dr. Alan Xenakis, MD announced today the release of ... new book, DOC X MD Funny Feelings translates ... style with humor and medical accuracy. The book is creatively ... answers to those age-old questions that most folks are embarrassed ... do mosquitoes bite some and not others? Why do folks ...
(Date:7/28/2014)... Cuidado Casero , an organization of Medicare ... PHC in Texas, New Mexico, New Jersey, Virginia, and Puerto ... Texas Chapter of PAM’s 2014 Gala. , North Texas ... The North Texas chapter was created by a handful of ... improving medical care for the indigent in Peru. The chapter ...
(Date:7/27/2014)... Hyaluronic Acid can hold 1,000 times ... to the power of Hyaluronic Serums. , "Hyaluronic acid ... of Sublime Beauty®. "But like collagen, it diminishes with ... improves skin moisture-retention and radiance." , Hyaluronic acid ... healthy and beautiful look. Key Ingredients in the serum ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Manufacturers of ... with organic ways to achieve a younger appearance. The ... buyer's guide to help men and women explore the ... The details that are presented in the posted guide ... price information for consumers. On drawback to some natural ...
(Date:7/27/2014)... Two new pill-only antiviral drug regimens could provide shorter, ... the majority of patients infected with hepatitis C, even ... of two studies published in The Lancet . ... which is the most common genotype in the USA, ... of the most difficult to treat. , Around 150 ...
Breaking Medicine News(10 mins):Health News:New Book by Alan P. Xenakis, MD Reveals Mind and Body Mysteries 2Health News:Cuidado Casero Sponsors Peruvian American Medical Society (PAMS) Gala 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 3
... recent issue of the journal Thorax, researchers have emphasized// ... looked into the data provided by 2401 subjects who ... and incidence of tuberculosis disease. Of the total ... skin test. The research results have showed that the ...
... is an important component of mammal’s daily life and more so ... are known to sleep for over 18 hours. However, it is ... has been reported in Nature that newborn bottlenose dolphins and killer ... Their moms manage with only a wink or two than the ...
... has published a major retrospective study that indicates // that ... infertility. ,Dr. Louise A. Brinton, of the National ... U.S. women treated for infertility between 1965 and 1988. She ... general population. The women were followed for a median of ...
... when in the womb of the mother, may have asthma ... had conducted an 11-year observation of incidence of asthma and ... significantly related to incidence of asthma in childhood. Passive smoking ... the incidence of asthma in children. ,Researchers are of ...
... (RPI), they have stated that have received the ... store in the US, for outstanding performance in the ... company with more than 1.3 million associates worldwide and ... , ,RPI is based in Jacksonville, Florida, USA ...
... who had long earlier published their findings on strong links ... up with the results from the next part of the ... ,The follow up data of the research point out ... regularly through their childhood are four times as likely to ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: